PFE - Pfizer - Stock Forecast

Healthcare - Sector
Coverage Profile Stock analysts Price Targets & Ratings Chart Insider Trading

PFE is currently covered by 20 analysts with an average price target of $36.45. This is a potential upside of $7.57 (26.21%) from yesterday's end of day stock price of $28.88.

Pfizer's activity chart (see below) currently has 234 price targets and 267 ratings on display. The stock rating distribution of PFE is 48.24% BUY and 51.76% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.39% with an average time for these price targets to be met of 577.39 days.

Highest price target for PFE is $45, Lowest price target is $28, average price target is $36.45.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 02-May-2024. First documented stock forecast 12-Feb-2009.

What is Pfizer?

Pfizer is a global bio pharmaceutical company that engages in the discovery, development, manufacturing, marketing, distribution, and sale of medicines and vaccines for various therapeutic areas. The company has been a leading innovator in healthcare and bio pharmaceuticals for over 170 years since its foundation in 1849. Pfizer’s success stems from its pioneering efforts in developing new medicines and vaccines to treat and prevent diseases. The company’s discovery of penicillin is among its most famous contributions to medicine.

What made Pfizer famous?

Pfizer’s pioneering efforts in developing new medicines and vaccines to treat and prevent diseases largely attribute to its success. One of its most famous contributions to medicine is the discovery of penicillin. Pfizer has a long history of developing innovative drugs that address unmet medical needs like the Prevnar vaccine for pneumococcal disease.

What are the most products or services of Pfizer?

Eliquis

Doctors prescribe Eliquis to prevent blood clots and reduce the risk of stroke in patients with certain heart and blood vessel conditions. It works by blocking certain clotting proteins in the blood.

Nurtec ODT/Vydura

Nurtec ODT/Vydura treats migraines in adults. It works by blocking the release of certain chemicals in the brain that cause migraines.

Premarin family

Doctors use the Premarin family of hormone replacement therapy products to treat symptoms of menopause in women. They work by supplementing the estrogen hormones that decrease during menopause.

Prevnar family

The Prevnar family of vaccines prevents infections caused by pneumococcal bacteria, including pneumonia, meningitis, and sepsis. The vaccines work by stimulating the body’s immune system to produce antibodies against the bacteria.

Nimenrix

Doctors use Nimenrix as a vaccine to prevent meningococcal disease. It works by stimulating the body’s immune system to produce antibodies against the bacteria that cause the disease.

FSME/IMMUN-TicoVac

FSME/IMMUN-TicoVac prevents tick-borne encephalitis through vaccination. It works by stimulating the body’s immune system to produce antibodies against the virus that causes the disease.

Trumenba

Trumenba prevents meningococcal disease caused by certain strains of bacteria. It works by stimulating the body’s immune system to produce antibodies against the bacteria.

Comirnaty

Pfizer developed Comirnaty as a vaccine to prevent COVID-19. It works by teaching the body’s immune system to recognize and fight the virus that causes COVID-19.

Paxlovid

Doctors use Paxlovid to treat COVID-19 in patients who are at high risk for severe illness. It works by blocking the activity of certain proteins that the virus needs to replicate and spread in the body.

Xeljanz

Xeljanz treats certain immune and inflammatory diseases, such as rheumatoid arthritis and ulcerative colitis. It works by blocking certain enzymes that contribute to inflammation.

Enbrel

Enbrel treats immune and inflammatory diseases, such as rheumatoid arthritis and psoriasis. It works by blocking the activity of certain proteins that contribute to inflammation.

Inflectra

Inflectra treats immune and inflammatory diseases, such as Crohn’s disease and ulcerative colitis, as a biosimilar medication. It works by blocking the activity of certain proteins that contribute to inflammation.

Eucrisa/Staquis

Eucrisa/Staquis is a medication used to treat eczema. It works by blocking certain enzymes that contribute to inflammation and itching.

Cibinqo

Cibinqo is a biosimilar medication used to treat certain immune and inflammatory diseases, such as rheumatoid arthritis. It works by blocking the activity of certain proteins that contribute to inflammation.

Vyndaqel family

Vyndaqel family of medications treats the buildup of abnormal proteins in the body that can lead to various diseases. They work by stabilizing the proteins and preventing them from causing damage.

Oxbryta

Oxbryta is a medication used to treat sickle cell disease. It works by increasing the amount of oxygen that red blood cells can carry, which can help to reduce the symptoms of the disease.

BeneFIX

BeneFIX is a medication used to treat hemophilia B. Patients with the disease benefit from the replacement of the clotting factor that is missing or not working properly.

Genotropin

Genotropin is a medication used to treat growth hormone deficiency. It works by stimulating the growth of bones and muscles in the body.

Sulperazon

Sulperazon is a medication used to treat bacterial infections. It works by stopping the growth and spread of bacteria in the body.

Medrol

Doctors use Medrol to treat various conditions, such as inflammation, allergic reactions, and certain cancers. It works by suppressing the immune system and reducing inflammation in the body.

Zavicefta

Zavicefta is a medication used to treat bacterial infections.

Currently out of the existing stock ratings of PFE, 41 are a BUY (48.24%), 44 are a HOLD (51.76%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

29

$0.12 (0.42%)

37

24 days ago

7/17 (41.18%)

$1.3 (4.69%)

206

0.93

Buy

45

$16.12 (55.82%)

45

1 months 8 days ago

9/28 (32.14%)

$19.61 (77.24%)

780

0.3

Buy

36

$7.12 (24.65%)

55

3 months 3 days ago

15/19 (78.95%)

$8.24 (29.68%)

440

6.46

Hold

29

$0.12 (0.42%)

27

4 months 9 days ago

3/8 (37.5%)

$1.27 (4.58%)

632

1.33

Hold

32

$3.12 (10.80%)

70

4 months 22 days ago

3/5 (60%)

$3.34 (11.65%)

1766

0.22

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PFE (Pfizer) average time for price targets to be met?

On average it took 577.39 days on average for the stock forecasts to be realized with a an average price target met ratio 63.39

Which analyst has the current highest performing score on PFE (Pfizer) with a proven track record?

RICHARD PURKISS

Which analyst has the most public recommendations on PFE (Pfizer)?

Richard Purkiss has 7 price targets and 7 ratings on PFE

Which analyst is the currently most bullish on PFE (Pfizer)?

Aaron Gal with highest potential upside - $38.41

Which analyst is the currently most reserved on PFE (Pfizer)?

Carter Gould with lowest potential downside - -$0.88

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?